Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

Delayed Data
As of May 25
 -1.30 / -5.34%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 12.00. The median estimate represents a -26.25% decrease from the last price of 23.05.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Momenta Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 42.16%
Growthannually -31.62%


Growthquarterly 347.68%
Growthannually -41.28%
Key to the earnings and sales forecast charts.